Successful blood pressure control in the African American Study of Kidney Disease and Hypertension.
暂无分享,去创建一个
Jackson T. Wright | T. Greene | N. Rogers | S. Massry | L. Agodoa | J. Lash | J. Douglas | O. Randall | G. Contreras | Michael C. Smith | J. Wright
[1] P Whelton,et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.
[2] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[3] H. Black,et al. Current concepts refractory hypertension , 1992 .
[4] W. L. Ooi,et al. Impact of Race on Treatment Response and Cardiovascular Disease Among Hypertensives , 1989, Hypertension.
[5] C. Bulpitt,et al. Quality of life of elderly patients with isolated systolic hypertension: baseline data from the Syst‐Eur Trial , 1998 .
[6] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[7] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[8] Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race-sex and blood pressure level. A further analysis. Hypertension Detection and Follow-up Program Cooperative Group. , 1984, Journal of community health.
[9] E. Roccella,et al. Hypertension-related morbidity and mortality in the southeastern United States. , 1997, The American journal of the medical sciences.
[10] Mahboob Rahman,et al. Pathophysiology and treatment implications of hypertension in the African-American population. , 1997, Endocrinology and metabolism clinics of North America.
[11] R. Toto,et al. Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. , 1996, Controlled clinical trials.
[12] C. Lewis,et al. Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. , 1996, Archives of internal medicine.
[13] Stella M. Yu. Healthy People 2010 , 1998, Maternal and Child Health Journal.
[14] I. Wiklund,et al. Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study. , 1997, Blood pressure.
[15] B. Morgenstern,et al. Human blood pressure determination by sphygmomanometry. , 1993, Circulation.
[16] H. Black,et al. Refractory hypertension. , 1992, The New England journal of medicine.
[17] M. Pfeffer,et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] A. Levey,et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. , 1997, Hypertension.
[19] G. Bakris,et al. Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients. , 1999, American journal of hypertension.
[20] R. Schrier,et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. , 2000, Diabetes care.
[21] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[22] Lippincott Williams Wilkins,et al. National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes , 1994, Hypertension.